219 related articles for article (PubMed ID: 11319909)
21. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
22. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA
Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492
[TBL] [Abstract][Full Text] [Related]
23. Molecular target-based therapy of pancreatic cancer.
Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
[TBL] [Abstract][Full Text] [Related]
24. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
25. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
[TBL] [Abstract][Full Text] [Related]
27. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
Xu Y; Deng GR; Liang YY; Li C
Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
[TBL] [Abstract][Full Text] [Related]
28. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
[TBL] [Abstract][Full Text] [Related]
29. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
Kondraganti S; Mohanam S; Chintala SK; Kin Y; Jasti SL; Nirmala C; Lakka SS; Adachi Y; Kyritsis AP; Ali-Osman F; Sawaya R; Fuller GN; Rao JS
Cancer Res; 2000 Dec; 60(24):6851-5. PubMed ID: 11156378
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting.
Jover R; Bort R; Gómez-Lechón MJ; Castell JV
Hepatology; 2001 Mar; 33(3):668-75. PubMed ID: 11230748
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of adenovirus-mediated gene transfer of antisense matrix metalloproteinase-2 on hepatocellular carcinoma growth in vivo].
Zhang MM; Yan LN; Li DH; Gou XH; Liu JW; Su Z; Han L; Zhao LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):671-4. PubMed ID: 16174456
[TBL] [Abstract][Full Text] [Related]
33. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.
Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE
J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo.
Vidic S; Markelc B; Sersa G; Coer A; Kamensek U; Tevz G; Kranjc S; Cemazar M
Cancer Gene Ther; 2010 Jun; 17(6):409-19. PubMed ID: 20094071
[TBL] [Abstract][Full Text] [Related]
35. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
36. Expression of cathepsin S antisense transcripts by adenovirus in retinal pigment epithelial cells.
Rakoczy PE; Lai MC; Baines MG; Spilsbury K; Constable IJ
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2095-104. PubMed ID: 9761288
[TBL] [Abstract][Full Text] [Related]
37. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
Cho YS; Cho-Chung YS
Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
[TBL] [Abstract][Full Text] [Related]
38. Expression profiles of pancreatic cancer cell lines infected with antisense K-ras-expressing adenoviral vector.
Ohnami S; Aoki K; Yoshida K; Ohnami S; Hatanaka K; Suzuki K; Sasaki H; Yoshida T
Biochem Biophys Res Commun; 2003 Oct; 309(4):798-803. PubMed ID: 13679043
[TBL] [Abstract][Full Text] [Related]
39. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
40. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
Liu Y; Bodmer WF
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
